MA53614A - Protéine pour le traitement de maladies inflammatoires - Google Patents

Protéine pour le traitement de maladies inflammatoires

Info

Publication number
MA53614A
MA53614A MA053614A MA53614A MA53614A MA 53614 A MA53614 A MA 53614A MA 053614 A MA053614 A MA 053614A MA 53614 A MA53614 A MA 53614A MA 53614 A MA53614 A MA 53614A
Authority
MA
Morocco
Prior art keywords
protein
treatment
inflammatory diseases
inflammatory
diseases
Prior art date
Application number
MA053614A
Other languages
English (en)
Inventor
Mamata Katdare
Sudeep Kumar
Dhananjay Sathe
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Publication of MA53614A publication Critical patent/MA53614A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA053614A 2018-09-16 2019-09-14 Protéine pour le traitement de maladies inflammatoires MA53614A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201821009667 2018-09-16

Publications (1)

Publication Number Publication Date
MA53614A true MA53614A (fr) 2021-07-21

Family

ID=68165661

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053614A MA53614A (fr) 2018-09-16 2019-09-14 Protéine pour le traitement de maladies inflammatoires

Country Status (15)

Country Link
US (1) US20220047671A1 (fr)
EP (1) EP3849586B1 (fr)
JP (1) JP7350843B2 (fr)
KR (1) KR102808511B1 (fr)
CN (1) CN113286604B (fr)
AU (1) AU2019358599B2 (fr)
BR (1) BR112021004792A2 (fr)
CA (1) CA3112250A1 (fr)
EA (1) EA202190310A1 (fr)
MA (1) MA53614A (fr)
MX (1) MX2021003109A (fr)
MY (1) MY205028A (fr)
SG (1) SG11202102501XA (fr)
WO (1) WO2020074984A1 (fr)
ZA (1) ZA202101587B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230008072A (ko) * 2020-05-07 2023-01-13 유니켐 레버러토리스 리미티드 항암 단백질
WO2022149068A1 (fr) * 2021-01-07 2022-07-14 Unichem Laboratories Ltd Protéine lectine pour le traitement et la prévention de maladies neurodégénératives
CN112716928B (zh) * 2021-02-22 2022-05-24 华南理工大学 辣椒素在抑制nlrp3炎症小体活化中的应用
CA3223964A1 (fr) 2021-07-08 2023-01-12 Dhananjay Sathe Proteines recombinantes, compositions et procedes de stabilisation de celles-ci
CN117858717A (zh) 2021-08-30 2024-04-09 联合化学实验室有限公司 用于治疗炎症性疾病的蛋白质组合物
MX2024006888A (es) 2021-12-16 2024-06-19 Unichem Lab Ltd Proteina recombinante para la enfermedad sars-cov2.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219905D0 (en) * 1992-09-19 1992-11-04 Univ Liverpool Lectins
JPH08501569A (ja) * 1992-10-02 1996-02-20 アルバータ リサーチ カウンスル 糖質結合ペプチドの抗炎症性、免疫寛容原性、および免疫阻害性
GB9907429D0 (en) * 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
WO2010050369A1 (fr) * 2008-10-31 2010-05-06 国立大学法人岡山大学 Agent prophylactique pour des caries dentaires
HRP20190208T1 (hr) 2009-02-18 2019-04-05 Unichem Laboratories Limited Rekombinantni lektini koji vežu stanice raka s antitumorskom aktivnošću i metodom preparacije
WO2014203261A2 (fr) * 2010-02-02 2014-12-24 Unichem Laboratories Ltd. Lectine recombinée et son procédé de préparation

Also Published As

Publication number Publication date
KR102808511B1 (ko) 2025-05-14
ZA202101587B (en) 2022-07-27
EP3849586A1 (fr) 2021-07-21
EP3849586B1 (fr) 2026-03-11
AU2019358599B2 (en) 2024-11-28
SG11202102501XA (en) 2021-04-29
KR20210058852A (ko) 2021-05-24
JP2022500040A (ja) 2022-01-04
CA3112250A1 (fr) 2020-04-16
MY205028A (en) 2024-09-28
AU2019358599A1 (en) 2021-04-22
CN113286604A (zh) 2021-08-20
WO2020074984A1 (fr) 2020-04-16
EA202190310A1 (ru) 2021-07-01
US20220047671A1 (en) 2022-02-17
MX2021003109A (es) 2021-05-13
BR112021004792A2 (pt) 2021-08-03
CN113286604B (zh) 2023-05-12
JP7350843B2 (ja) 2023-09-26

Similar Documents

Publication Publication Date Title
EP3866781A4 (fr) Nouvelles compositions pour le traitement de maladies inflammatoires
MA49767A (fr) Conjugués de cytokine pour le traitement de maladies auto-immunes
EP3448875A4 (fr) Compositions pour le traitement de maladies
EP3448987A4 (fr) Compositions pour le traitement de maladies
MA53614A (fr) Protéine pour le traitement de maladies inflammatoires
EP3565846A4 (fr) Agents thérapeutiques protéiques pour le traitement de cellules sénescentes
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
EP3866777A4 (fr) Polythérapie pour le traitement de maladies inflammatoires
EP3612566A4 (fr) Anticorps antagonistes de cd 14 pour le traitement de maladies neurodégénératives
EP3820888A4 (fr) Systèmes co-récepteurs pour le traitement de maladies infectieuses
IL284125A (en) Quinoline derivatives for use in the treatment of inflammation diseases
EP4045036A4 (fr) Amides hétéroaryle-biphényle pour le traitement de maladies associées à pd-l1
MA45089A (fr) Utilisation d'indazoles 2-substitués pour le traitement et la prophylaxie de maladies auto-immunes
MA54077A (fr) Polythérapie pour le traitement de maladies hématologiques
EP3773629A4 (fr) Thérapies à base de car-treg pour le traitement de maladies neurodégénératives
MA55218A (fr) Eskétamine pour le traitement de la dépression
EP3316887A4 (fr) Inhibiteurs de gls1 pour le traitement de maladies
IL280664A (en) 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases
EP3727369A4 (fr) Test théragnostique pour le traitement antifongique de maladies inflammatoires
EP3735209A4 (fr) Traitement de la progression de la myopie
EP3737363A4 (fr) Méthodes de traitement de maladies inflammatoires chroniques
EP3843737A4 (fr) Inhibiteurs de pde9 pour le traitement de la drépanocytose
EP3413898A4 (fr) Utilisation de tréhalose pour le traitement de maladies neurologiques
EP3877382A4 (fr) Nouveaux composés pour le traitement de maladies respiratoires
EP3395341A4 (fr) Composition pour le traitement de maladies neuromotrices et son utilisation